The development marks an important step in addressing the continent’s reliance on imported treatments and vaccines
The first Moroccan-produced tests to diagnose breast cancer and leukaemia will become commercially available within months, cutting costs and waiting times for patients in the country and across Africa.
Most of the diagnostic kits for cancer and other diseases in Africa are expensive imports from outside the continent, usually from Europe and the US.
Continue reading...